# MICAFUNGIN SODIUM
> **ANDA213363** · Abbreviated New Drug Application (Generic) · Sponsor: JIANGSU HANSOH PHARM · Approved 2021-07-09
## Drug
- **FDA Application Number:** ANDA213363
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MICAFUNGIN SODIUM
- **Generic name:** MICAFUNGIN SODIUM
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** JIANGSU HANSOH PHARM
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2021-07-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213363)
---
*MORVS · CC0 1.0*